Data / Form D filings / Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc.: Form D filings
Viewpoint Molecular Targeting, Inc., a biotechnology company in Coralville, IA, filed 5 Form D notices with the SEC between 2019 and 2021. The latest, on January 15, 2021, reports $14.3 million sold of a $15.8 million offering to 29 investors.
Find out what Viewpoint Molecular Targeting, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2500 CROSSPARK ROAD E-116, Coralville, IA, 52241
- Phone
- (865) 356-1861
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1768245
The full lists. Form D filings in Iowa: 206 rows, $10.30, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 15, 2021 | Amendment | $15,847,498 | $14,258,742 | $1,588,756 | 29 | Nov 20, 2020 | sec.gov |
| Dec 30, 2020 | Amendment | $15,847,498 | $12,038,744 | $3,808,754 | 28 | Nov 20, 2020 | sec.gov |
| Dec 4, 2020 | New notice | $15,847,498 | $8,843,739 | $7,003,759 | 26 | Nov 20, 2020 | sec.gov |
| Jun 18, 2020 | Amendment | $2,000,000 | $750,000 | $1,250,000 | 10 | Feb 6, 2019 | sec.gov |
| Feb 19, 2019 | New notice | $2,000,000 | $600,000 | $1,400,000 | 7 | Feb 6, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Schultz | Executive Officer, Director | |
| Curtis Nelson | Director | |
| Heyward Coleman | Executive Officer, Director | |
| Cameron Gray | Director | |
| Frances Johnson | Executive Officer, Director |
Every Form D from the week of Jan 11, 2021 · All recent filings in Iowa · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Viewpoint Molecular Targeting, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.